Bridget Charbonneau

Bridget Charbonneau is the Senior Director of Global Scientific Communications at Eli Lilly and Company, where they have held various roles since 2018. Previously, they served as a Senior Director for Publication Strategy and Execution at Eli Lilly from 2018 to 2022 and worked as a Consultant in the same department. Bridget completed two postdoctoral fellowships, one in Pediatric Cancer Epidemiology at the University of Minnesota and another in Cancer Genetic Epidemiology at the Mayo Clinic. They earned a PhD in Microbiology from the University of Iowa and a Master of Public Health in Epidemiology from the University of Minnesota. Additionally, Bridget holds a BA in Biology and Chemistry from the College of Saint Benedict.